Gabriel Dielacher

Valutico is the world’s leading valuation platform. With Valutico’s software, you can value a business in minutes. An award-winning fintech providing a range of company valuation solutions, Valutico provides the financial services industry and valuation experts with data-driven tools to perform accurate company valuations faster and more accurately than ever before. With 9 of the world’s leading valuation methods to choose from, and 28 powerful variations, Valutico often cuts the time to perform valuations in half. The all-in-one platform comprises three modules - The modules address specific valuation requirements for private or listed enterprises and provide access to industry and country specific valuation parameters. Valutico’s offering is widely used by valuation experts in Advisory (e.g. Corporate Finance, M&A, Tax and Audit), Investment Management (e.g. Family Offices, Private Equity, Venture Capital), as well as Corporates (e.g. Strategy, Financial Reporting, IR). By combining advanced technology with expert corporate finance know-how, Valutico supports our clients to overcome every challenge of the valuation process, which demands technical and industry know-how, access to expensive financial databases and time. Our team of more than 65 employees is globally distributed and serves both national and international clients in over 90 countries.

GenePlanet is the leading European provider of preventive genetic tests, specialising in NIPT, cancer screening, and lifestyle DNA tests.   With over 18 years of experience in the market, GenePlanet collaborates with over 5000 medical centres, doctors, and insurance companies to provide top-quality tests based on the latest scientific discoveries. The company’s tests are designed to empower individuals to take control of their and their baby’s health, as well as assist doctors with therapeutic procedures. GenePlanet adheres to the highest standards of quality and is constantly striving for new discoveries through its research and development efforts. With a presence in more than 50 countries worldwide and over 500.000 satisfied customers, GenePlanet has been recognised as one of the 1000 fastest-growing companies in the EU by the Financial Times and one of the Top 35 EU Unicorns by the European Commission.

Valutico is the world’s leading valuation platform. With Valutico’s software, you can value a business in minutes. An award-winning fintech providing a range of company valuation solutions, Valutico provides the financial services industry and valuation experts with data-driven tools to perform accurate company valuations faster and more accurately than ever before. With 9 of the world’s leading valuation methods to choose from, and 28 powerful variations, Valutico often cuts the time to perform valuations in half. The all-in-one platform comprises three modules - The modules address specific valuation requirements for private or listed enterprises and provide access to industry and country specific valuation parameters. Valutico’s offering is widely used by valuation experts in Advisory (e.g. Corporate Finance, M&A, Tax and Audit), Investment Management (e.g. Family Offices, Private Equity, Venture Capital), as well as Corporates (e.g. Strategy, Financial Reporting, IR). By combining advanced technology with expert corporate finance know-how, Valutico supports our clients to overcome every challenge of the valuation process, which demands technical and industry know-how, access to expensive financial databases and time. Our team of more than 65 employees is globally distributed and serves both national and international clients in over 90 countries.

Onsight Ventures is at the forefront of early-stage investments in cutting-edge technologies, specializing in computing, semiconductors, synthetic biology (synbio), and biotechnology. As a visionary deep tech fund, Onsight takes a primary investment approach in the dynamic landscape of Europe, positioning itself as a catalyst for the growth and success of groundbreaking innovations in these transformative fields. Subscribe to our Newsletter for the latest insights and updates: bit.ly/onsightinsightsnewsletter Have you missed a LinkedIn Audio Event? Do not worry, you can listen to all episodes here: https://open.spotify.com/show/7qJZztS6qeVgGbAYY0EIIA?si=f034b8df21824c24

GenePlanet is the leading European provider of preventive genetic tests, specialising in NIPT, cancer screening, and lifestyle DNA tests.   With over 18 years of experience in the market, GenePlanet collaborates with over 5000 medical centres, doctors, and insurance companies to provide top-quality tests based on the latest scientific discoveries. The company’s tests are designed to empower individuals to take control of their and their baby’s health, as well as assist doctors with therapeutic procedures. GenePlanet adheres to the highest standards of quality and is constantly striving for new discoveries through its research and development efforts. With a presence in more than 50 countries worldwide and over 500.000 satisfied customers, GenePlanet has been recognised as one of the 1000 fastest-growing companies in the EU by the Financial Times and one of the Top 35 EU Unicorns by the European Commission.